Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A Synthetic Strategy for Conjugation of Paromomycin to Cell-Penetrating Tat(48-60) for Delivery and Visualization into Leishmania Parasites

  • Defaus, Sira
  • Gallo, María, 1989-
  • Abengózar, María Ángeles
  • Rivas, Luis
  • Andreu Martínez, David
A successful approach to deliver paromomycin, a poorly absorbed aminoglycoside antibiotic, to parasite cells is reported, based on selective protection of amino and hydroxyl groups followed by conjugation to a fluorolabeled, PEG-functionalized cell-penetrating Tat(48-60) peptide. The resulting construct is efficiently internalized into Leishmania cells, evidencing the fitness of cell-penetrating peptides as vectors for efficiently transporting low-bioavailability drugs into cells., Work at Pompeu Fabra University was supported by Grants SAF2011-24899 and AGL2014-52395-C2-2-R from the Spanish Ministry of Economy and Competiveness (MINECO) to David Andreu; work at the Centro de Investigaciones Biológicas was supported by Grants PI12-02706 from ISCIII-FEDER, SAF2015-65740-R from MINECO to Luis Rivas, and RICET RD12/0018/0007 and RD16/0027/0010-FEDER.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Estimating peptide half‐life in serum from tunable, sequence‐related physicochemical properties

  • Cavaco, Marco
  • Valle, Javier
  • Flores, Isabel
  • Andreu Martínez, David
  • Castanho, Miguel A.R.B.
Proteolytic instability is a critical limitation for peptide-based products. Although significant efforts are devoted to stabilize sequences against proteases/peptidases in plasma/serum, such approaches tend to be rather empirical, unspecific, time-consuming, and frequently not cost-effective. A more rational and potentially rewarding alternative is to identify the chemical grounds of susceptibility to enzymatic degradation of peptides so that proteolytic resistance can be tuned by manipulation of key chemical properties. In this regard, we conducted a meta-analysis of literature published over the last decade reporting experimental data on the lifetimes of peptides exposed to proteolytic conditions. Our initial database contained 579 entries and was curated with regard to amino acid sequence, chemical modification, terminal half-life (t1/2 ) or other stability readouts, type of stability assay, and biological application of the study. Although the majority of entries in the database corresponded to (slightly or substantially) modified peptides, we chose to focus on unmodified ones, as we aimed to decipher intrinsic characteristics of peptide proteolytic susceptibility. Specifically, we developed a multivariable regression model to unravel those peptide properties with most impact on proteolytic stability and thus potential t1/2 predicting ability. Model validation was done by two different approaches. First, a library of peptides spanning a large interval of properties that modulate stability was synthesized and their t1/2 in human serum were experimentally determined. Second, the t1/2 of 21 selected peptides approved for clinical use or in clinical trials were recorded and matched with the model-estimated values. With both approaches, good correlation between experimental and predicted t1/2 data was observed., This research was supported by the Portuguese Fundação para a Ciência e a Tecnologia (FCT; grants PD/BD/128281/2017, PTDC/BBB‐NAN/1578/2014, PTDC/BIA‐VIR/29495/2017, UID/Multi/04349/2019, and PTDC/QUI‐NUC/30147/2017), the Spanish Ministry of Economy and Innovation (MINECO, grants AGL2014‐52395‐C2‐2‐R and AGL2017‐84097‐C2‐2‐R, and Maria de Maeztu Program for Centers of Excellence); the European Union H2020‐MSCA‐RISE‐2014 program (grant no. 828774), and the “La Caixa” Banking Foundation (grant HR17‐00409).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins

  • Dias, Susana A.
  • Miguel Freire, João
  • Pérez-Peinado, Clara, 1991-
  • Domingues, Marco M.
  • Gaspar, Diana
  • Vale, Nuno
  • Gomes, Paula
  • Andreu Martínez, David
  • Henriques, Sónia T.
  • Castanho, Miguel A.R.B.
  • Veiga, Ana Salomé
The increasing prevalence of multidrug-resistant bacteria urges the development of new antibacterial agents. With a broad spectrum activity, antimicrobial peptides have been considered potential antibacterial drug leads. Using bioinformatic tools we have previously shown that viral structural proteins are a rich source for new bioactive peptide sequences, namely antimicrobial and cell-penetrating peptides. Here, we test the efficacy and mechanism of action of the most promising peptides among those previously identified against both Gram-positive and Gram-negative bacteria. Two cell-penetrating peptides, vCPP 0769 and vCPP 2319, have high antibacterial activity against Staphylococcus aureus, MRSA, Escherichia coli, and Pseudomonas aeruginosa, being thus multifunctional. The antibacterial mechanism of action of the two most active viral protein-derived peptides, vAMP 059 and vCPP 2319, was studied in detail. Both peptides act on both Gram-positive S. aureus and Gram-negative P. aeruginosa, with bacterial cell death occurring within minutes. Also, these peptides cause bacterial membrane permeabilization and damage of the bacterial envelope of P. aeruginosa cells. Overall, the results show that structural viral proteins are an abundant source for membrane-active peptides sequences with strong antibacterial properties., This work was supported by Fundação para a Ciência e a Tecnologia (FCT-MCTES, Portugal) projects PTDC/QEQ-MED/4412/2014 and UID/QUI/50006/2013, and by Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE): call H2020-MSCA-RISE-2014, Grant agreement 644167, 2015–2019. SD, JF, and DG acknowledge FCT for fellowships PD/BD/114425/2016, SFRH/BD/70423/2010, and SFRH/BPD/109010/2015, respectively, and MD for a grant (PTDC/BBB-BQB/3494/2014). ASV and NV acknowledge FCT for funding within the FCT Investigator Programme, IF/00803/2012 and IF/00092/2014, respectively. CP-P acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through grant AGL2014-52395-C2-2-R and the “María de Maeztu” Programme for Units of Excellence in R&D (MDM-2014-0370). PG acknowledges “Comissão de Coordenação e Desenvolvimento Regional do Norte (CCDR-N)/NORTE2020/Portugal 2020” for funding through project DESignBIOtechHealth (ref. Norte-01-0145-FEDER-000024). SH is the recipient of an Australian Research Council Future Fellowship (FT150100398).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

  • Cebrià i Costa, Joan Pau, 1989-
  • Pascual-Reguant, Laura, 1990-
  • Gonzalez-Perez, Abel
  • Serra Bardenys, Gemma, 1992-
  • Querol, J.
  • Cosín Tomàs, Marta
  • Verde, Gaetano
  • Cigliano, Riccardo Aiese
  • Sanseverino, Walter
  • Segura-Bayona, Sandra
  • Iturbide Martínez de Albéniz, Ane, 1989-
  • Andreu Martínez, David
  • Nuciforo, Paolo G.
  • Bernado-Morales, C.
  • Rodilla, Verónica
  • Arribas, Joaquín
  • Yélamos López, José
  • García de Herreros, Antonio
  • Stracker, Travis
  • Peiró Sales, Sandra
Oxidation of H3 at lysine 4 (H3K4ox) by lysyl oxidase-like 2 (LOXL2) generates an H3 modification with an unknown physiological function. We find that LOXL2 and H3K4ox are higher in triple-negative breast cancer (TNBC) cell lines and patient-derived xenografts (PDXs) than those from other breast cancer subtypes. ChIP-seq revealed that H3K4ox is located primarily in heterochromatin, where it is involved in chromatin compaction. Knocking down LOXL2 reduces H3K4ox levels and causes chromatin decompaction, resulting in a sustained activation of the DNA damage response (DDR) and increased susceptibility to anticancer agents. This critical role that LOXL2 and oxidized H3 play in chromatin compaction and DDR suggests that functionally targeting LOXL2 could be a way to sensitize TNBC cells to conventional therapy., This work was supported by grants from Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI12/01250; CP08/00223; PI16/00253; and CB16/12/00449), MINECO (SAF2013-48849-C2-1-R) to SP, BFU2015-68354 to THS, Breast Cancer Research Foundation (BCRF-17-008) to JA, AGL2014-52395-C2-2-R to DA, Worldwide Cancer Research, Red Temática de Investigación Cooperativa en Cáncer (RD012/0036/005), Fundación Científica de la Asociación Española contra el Cáncer, and Fundació La Marató TV3.THS was supported by institutional funding (MINECO) through theCentres of Excellence Severo Ochoa award and the CERCA Pro-gramme of the Catalan Government, and SS-B, by a Fundació LaCaixa fellowship. We thank La Caixa Foundation and Cellex Foun-dation for provide research facilities and equipment. GV has received f unding from the MINECO (a “Juan de la Cierva Incorporation ” fellowship; IJCI-2014-20723). SP was a recipient of a Miguel Servet contract (ISCIII/FIS), and AI, JPC-C, LP-G, and GS-B are supported by contracts from Worldwide Cancer Research, Fundació La MaratóTV3, Fundació FERO, and a FI Fellowship from the Generalitat de Catalunya, respectively.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Co-administration of antimicrobial peptides enhances toll-like receptor 4 antagonist activity of a synthetic glycolipid

  • Facchini, Fabio A.
  • Coelho, Helena
  • Sestito, Stefania Enza
  • Delgado, Sandra
  • Minotti, Alberto
  • Andreu Martínez, David
  • Jiménez-Barbero, Jesús J.
  • Peri, Francesco
This study examines the effect of co-administration of antimicrobial peptides and the synthetic glycolipid FP7, which is active in inhibiting inflammatory cytokine production caused by TLR4 activation and signaling. The co-administration of two lipopolysaccharide (LPS)-neutralizing peptides (a cecropin A-melittin hybrid peptide and a human cathelicidin) enhances by an order of magnitude the potency of FP7 in blocking the TLR4 signal. Interestingly, this is not an additional effect of LPS neutralization by peptides, because it also occurs if cells are stimulated by the plant lectin phytohemagglutinin, a non-LPS TLR4 agonist. Our data suggest a dual mechanism of action for the peptides, not exclusively based on LPS binding and neutralization, but also on a direct effect on the LPS-binding proteins of the TLR4 receptor complex. NMR experiments in solution show that peptide addition changes the aggregation state of FP7, promoting the formation of larger micelles. These results suggest a relationship between the aggregation state of lipid A-like ligands and the type and intensity of the TLR4 response., This study was financially supported by the H2020‐MSC‐ETN‐642157 project TOLLerant. The Italian Ministry for Foreign Affairs and International Cooperation (MAECI) is acknowledged. Work at Pompeu Fabra University was supported by MINECO (grants SAF2011‐24899, AGL2014‐52395‐C2‐2‐R to D.A., CTQ2015‐64597‐C2‐1‐P and MINECO‐Severo Ochoa Excellence Acreditation 2017-2021 (SEV‐2016‐0644) to J.J.‐B.) with FEDER funds, and by Generalitat de Catalunya (2014SGR692).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Amyloid-β peptide nitrotyrosination stabilizes oligomers and enhances NMDAR-mediated toxicity

  • Guivernau Almazán, Biuse, 1988-
  • Bonet Martínez, Jaume, 1982-
  • Valls Comamala, Victòria, 1987-
  • Bosch Morató, Mònica, 1986-
  • Godoy Zeballos, Juan Alejandro, 1959-
  • Inestrosa, Nibaldo C.
  • Perálvarez Marín, Alex
  • Fernández-Busquets, Xavier
  • Andreu Martínez, David
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the pathological aggregation of the amyloid-β peptide (Aβ). Monomeric soluble Aβ can switch from helicoidal to β-sheet conformation, promoting its assembly into oligomers and subsequently to amyloid fibrils. Oligomers are highly toxic to neurons and have been reported to induce synaptic transmission impairments. The progression from oligomers to fibrils forming senile plaques is currently considered a protective mechanism to avoid the presence of the highly toxic oligomers. Protein nitration is a frequent post-translational modification under AD nitrative stress conditions. Aβ can be nitrated at tyrosine 10 (Y10) by peroxynitrite. Based on our analysis of ThT binding, Western blot and electron and atomic force microscopy, we report that Aβ nitration stabilizes soluble, highly toxic oligomers and impairs the formation of fibrils. We propose a mechanism by which fibril elongation is interrupted upon Y10 nitration: Nitration disrupts fibril-forming folds by preventing H14-mediated bridging, as shown with an Aβ analog containing a single residue (H to E) replacement that mimics the behavior of nitrated Aβ related to fibril formation and neuronal toxicity. The pathophysiological role of our findings in AD was highlighted by the study of these nitrated oligomers on mouse hippocampal neurons, where an increased NMDAR-dependent toxicity of nitrated Aβ oligomers was observed. Our results show that Aβ nitrotyrosination is a post-translational modification that increases Aβ synaptotoxicity. SIGNIFICANCE STATEMENT: We report that nitration (i.e., the irreversible addition of a nitro group) of the Alzheimer-related peptide amyloid-β (Aβ) favors the stabilization of highly toxic oligomers and inhibits the formation of Aβ fibrils. The nitrated Aβ oligomers are more toxic to neurons due to increased cytosolic calcium levels throughout their action on NMDA receptors. Sustained elevated calcium levels trigger excitotoxicity, a characteristic event in Alzheimer's disease., This work was supported by Spanish Plan Estatal de I+D+I 2013-2016 and the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación Grants PI13/00408 and Red HERACLES RD12/0042/0014 and FEDER Funds, Spanish Ministerio de Economía y Competitividad BIO2014-57518-R, BIO2014-52872-R, and AGL2014-52395-C2-2-R and FEDER Funds, the Generalitat de Catalunya (Spain) 2014-SGR-938, and Chilean Funds for Science CONICYTPFB 12/2007 and FONDECYT N° 1160724. A.P.-M. was the recipient of the Universitat Autònoma de Barcelona-Programa Banco de Santander Fellowship
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Lectin-binding specificity of the fertilization-relevant protein PDC-109 by means of surface plasmon resonance and carbohydrate recognition domain excision-mass spectrometry

  • Defaus, Sira
  • Avilés, Manuel
  • Andreu Martínez, David
  • Gutiérrez Gallego, Ricardo, 1968-
Seminal plasma proteins are relevant for sperm functionality and some appear responsible for establishing sperm interactions with the various environments along the female genital tract towards the oocyte. In recent years, research has focused on characterizing the role of these proteins in the context of reproductive biology, fertility diagnostics and treatment of related problems. Herein, we focus on the main protein of bovine seminal plasma, PDC-109 (BSP-A1/-A2), which by virtue of its lectin properties is involved in fertilization. By means of surface plasmon resonance, the interaction of PDC-109 with a panel of the most relevant glycosidic epitopes of mammals has been qualitatively and quantitatively characterized, and a higher affinity for carbohydrates containing fucose has been observed, in line with previous studies. Additionally, using the orthogonal technique of Carbohydrate REcognition Domain EXcision-Mass Spectrometry (CREDEX-MS), the recognition domain of the interaction complexes between PDC-109 and all fucosylated disaccharides [(Fuc-α1,(3,4,6)-GlcNAc)] has been defined, revealing the specific glycotope and the peptide domain likely to act as the PDC-109 carbohydrate binding site., This work was supported by grants BIO2009-08983 from MICINN (to R.G.G.), SAF2011-24899, AGL 2015-70159-P [FEDER] from MINECO (to Manuel Avilés) and AGL 2014-52395-C2-2-R [FEDER] from MINECO, and SGR2009 - 00492 from Generalitat de Catalunya (to David Andreu). PDC-109, purified from bull seminal plasma, was kindly donated by Juan José Calvete.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus

  • Bohórquez, José Alejandro
  • Defaus, Sira
  • Muñoz González, Sara
  • Perez-Simó, Marta
  • Rosell, Rosa
  • Fraile Sauce, Lorenzo José
  • Sobrino, Francisco
  • Andreu, David
  • Ganges, Llilianne
Three dendrimeric peptides were synthesized in order to evaluate their immunogenicity and their potential protection against classical swine fever virus (CSFV) in domestic pigs. Construct 1, an optimized version of a previously used dendrimer, had four copies of a B-cell epitope derived from CSFV E2 glycoprotein connected to an also CSFV-derived T-cell epitope through maleimide instead of thioether linkages. Construct 2 was similarly built but included only two copies of the B-cell epitope, and in also bivalent construct 3 the CSFV T-cell epitope was replaced by a previously described one from the 3A protein of foot-and-mouth disease virus (FMDV). Animals were inoculated twice with a 21-day interval and challenged 15days after the second immunization. Clinical signs were recorded daily and ELISA tests were performed to detect antibodies against specific peptide and E2. The neutralising antibody response was assessed 13days after challenge. Despite the change to maleimide connectivity, only partial protection against CSFV was again observed. The best clinical protection was observed in group 3. Animals inoculated with constructs 2 and 3 showed higher anti-peptide humoral response, suggesting that two copies of the B-cell epitope are sufficient or even better than four copies for swine immune recognition. In addition, for construct 3 higher neutralizing antibody titres against CSFV were detected. Our results support the immunogenicity of the CSFV B-cell epitope and the cooperative role of the FMDV 3A T-cell epitope in inducing a neutralising response against CSFV in domestic pigs. This is also the first time that the FMDV T-cell epitope shows effectivity in improving swine immune response against a different virus. Our findings highlight the relevance of dendrimeric peptides as a powerful tool for epitope characterization and antiviral strategies development., The research in CReSA was supported by grant AGL2015-66907 from the Spanish government. J.A. B. had a pre-doctoralfellowship FPI-MINECO 2016 from Spanish government. S. M.had a pre-doctoral fellowship FI-DGR 2014 from AGAUR, Gen-eralitat de Catalunya. Work at CBMSO was supported by grantsAGL2014-52395-C2-01 (MINECO, Spain) and S2013/ABI-2906-PLATESA (Comunidad Autónoma de Madrid). Work at UPF wasfunded by AGL2014-52395-C2-02 (MINECO, Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model

  • Rodríguez, María J.
  • Ramos-Soriano, Javier
  • Perkins, James R.
  • Mascaraque, Ainhoa
  • Torres, María José
  • Gómez, Francisca
  • Díaz-Perales, Araceli
  • Rojo, Francisco Javier
  • Mayorga, Cristobalina
An effective specific immunotherapy should contain elements to generate specific recognition (T-cell peptides) and to modulate the immunological response towards a Th1/Treg pattern by enhancing dendritic cells (DCs). We propose a novel sublingual immunotherapy for peach allergy, using systems, that combine Prup3-T-cell peptides with mannose dendrons (D1ManPrup3 and D4ManPrup3). Peach anaphylactic mice were treated 1, 2 and 5 nM concentrations. Tolerance was assessed one/five weeks after finishing treatment by determining in vivo/in vitro parameters after challenge with Prup3. Only mice receiving D1ManPrup3 at 2 nM were protected from anaphylaxis (no temperature changes, decrease in Prup3-sIgE and -sIgG1 antibody levels, and secreting cells) compared to PBS-treated mice. Moreover, an increase of Treg-cells and regulatory cytokines (IL-10+/IFN-γ+) in CD4+-T-cells and DCs were found. These changes were maintained at least five weeks after stopping treatment. D1ManPrup3 is an effective new approach of immunotherapy inducing protection from anaphylaxis which persists after finishing treatment., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pru p 3‐Epitope‐based sublingual immunotherapy in a murine model for the treatment of peach allergy

  • Rodriguez, Maria, J.
  • Mascaraque, Ainhoa
  • Ramos-Soriano, Javier
  • Torres, María José
  • Perkins, James R.
  • Gómez, Francisca
  • Garrido-Arandia, María
  • Cubells-Baeza, Nuria
  • Andreu, David
  • Díaz-Perales, Araceli
  • Rojo, Francisco Javier
  • Mayorga, Cristobalina
[Scope] Food‐specific immunotherapy (SIT) is a promising treatment for lipid transfer protein (LTP)‐syndrome. We propose a novel sublingual‐SIT (SLIT) that combines a Pru p 3 T‐cell peptide and an oligodeoxyribonucleotide (ODN) with CpG motifs (ODN‐CpG) as adjuvants to induce a specific Th1/Treg response., [Methods and results] LTP‐peach allergic mice were treated sublingually with a combination of a CpG sequence and mono‐ or tetravalent systems including a Pru p 3 peptide, D1(Prup3) or D4(Prup3). Mice were challenged intraperitoneally with Pru p 3 one or three weeks after SLIT and tolerance was assessed. Mice treated with D1(Prup3)+CpG were protected from anaphylaxis after Pru p 3 challenge. They showed no change in body temperature, lower levels of Pru p 3‐specific IgE and IgG1 antibodies and higher levels of sIgG2a compared to the untreated group. They had fewer IgE and IgG1 secreting cells and more sIgG2a secreting cells. Moreover, a significantly lower number of Pru p 3‐specific CD4+T cells and a higher number of Treg cells were found, alongside a Th1 cytokine pattern. These changes were maintained for three weeks after stopping treatment., [Conclusion] D1Prup3+CpG represents a promising SIT for food allergy. It is easily synthesized and induces protection from anaphylaxis to Pru p 3 that is maintained for at least three weeks., The study was funded by the Institute of Health “Carlos III” of the Ministry of Economy and Competitiveness: PI12/02481 and PI15/00559, RETICS RIRAAF (RD12/0013/0001, RD12/0013/0014, RD12/0013/0016), RETICS ARADyAL (RD16/0006/0001 RD16/0006/0003 and RD16/0006/0011) and Sara Borrell Program (CD14/00242). Andalusian Regional Ministry of Economy and Knowledge: CTS‐7433), Nicolas Monardes Program (C‐0044‐2012 SAS2013) and the Spanish Ministry of Economy and Competitiveness (CTQ2014‐52328‐P and AGL2014‐52395‐C2‐2). Grants were cofunded by the European Regional Development Fund (ERDF)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum Stability

  • Sandín, Daniel
  • Valle, Javier
  • Chaves-Arquero, Belén
  • Prats-Ejarque, Guillem
  • Larrosa, M. N.
  • González-López, Juan J.
  • Jiménez, M. Angeles
  • Boix, Ester
  • Andreu, David
  • Torrent, Marc
11 pags., 6 figs., 5 tabs., Multidrug resistance against conventional antibiotics poses an important threat to human health. In this context, antimicrobial peptides (AMPs) have been extensively studied for their antibacterial activity and promising results have been shown so far. However, AMPs tend to be rather vulnerable to protease degradation, which offsets their therapeutic appeal. Here, we demonstrate how replacing functional residues in the antimicrobial region of human RNase 3 - also named eosinophil cationic protein - by non-natural amino acids increases stability in human serum. These changes were also shown to reduce the hemolytic effect of the peptides in general terms, whereas the antimicrobial activity was reasonably preserved. Digestion profiles enabled us to design new peptides with superior stability and lower toxicity that could become relevant candidates to reach clinical stages., This work was supported by the Spanish Ministerio de Ciencia, Innovacion y Universidades: SAF2015-72518-EXP, SAF2017- ́ 82158-R and RYC-2012-09999 to M.T.; CTQ2017-84371-P to M.A.J.; AGL2014-52395-C2; AGL2017-84097-C2-2-R to D.A. and PID2019-106123GB-I00 to E.B. Additional financial support from the European Society for Clinical Microbiology and Infectious Disease, ESCMID 2016, to M.T., the Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement de la Generalitat de Catalunya, 2019 LLAV 00029 to M.T. and 2016 PROD 00060 to E.B. The “Marí a de Maeztu” Program for Units of Excellence in R&D from the Spanish Ministry of Innovation and Competitiveness (MINECO) for work at Pompeu Fabra University (D.A.) is acknowledged. This work was supported, in part, by the European Regional Development Fund ‘A Way to Achieve Europe’ [Spanish Network for Research in Infectious Diseases (Grant No. RD16/0016/0003)]. D.S. and B.C.-A. are recipients of pre-doctoral FPI scholarships (PRE2018-083243 and BES-2015-073383, respectively) from the Spanish Ministerio de Ciencia, Innovacion y Universidades.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A Synthetic Strategy for Conjugation of Paromomycin to Cell-Penetrating Tat(48-60) for Delivery and Visualization into Leishmania Parasites

  • Defaus, Sira
  • Gallo, María, 1989-
  • Abengózar, María Ángeles
  • Rivas, Luis
  • Andreu Martínez, David
A successful approach to deliver paromomycin, a poorly absorbed aminoglycoside antibiotic, to parasite cells is reported, based on selective protection of amino and hydroxyl groups followed by conjugation to a fluorolabeled, PEG-functionalized cell-penetrating Tat(48-60) peptide. The resulting construct is efficiently internalized into Leishmania cells, evidencing the fitness of cell-penetrating peptides as vectors for efficiently transporting low-bioavailability drugs into cells., Work at Pompeu Fabra University was supported by Grants SAF2011-24899 and AGL2014-52395-C2-2-R from the Spanish Ministry of Economy and Competiveness (MINECO) to David Andreu; work at the Centro de Investigaciones Biológicas was supported by Grants PI12-02706 from ISCIII-FEDER, SAF2015-65740-R from MINECO to Luis Rivas, and RICET RD12/0018/0007 and RD16/0027/0010-FEDER.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Estimating peptide half‐life in serum from tunable, sequence‐related physicochemical properties

  • Cavaco, Marco
  • Valle, Javier
  • Flores, Isabel
  • Andreu Martínez, David
  • Castanho, Miguel A.R.B.
Proteolytic instability is a critical limitation for peptide-based products. Although significant efforts are devoted to stabilize sequences against proteases/peptidases in plasma/serum, such approaches tend to be rather empirical, unspecific, time-consuming, and frequently not cost-effective. A more rational and potentially rewarding alternative is to identify the chemical grounds of susceptibility to enzymatic degradation of peptides so that proteolytic resistance can be tuned by manipulation of key chemical properties. In this regard, we conducted a meta-analysis of literature published over the last decade reporting experimental data on the lifetimes of peptides exposed to proteolytic conditions. Our initial database contained 579 entries and was curated with regard to amino acid sequence, chemical modification, terminal half-life (t1/2 ) or other stability readouts, type of stability assay, and biological application of the study. Although the majority of entries in the database corresponded to (slightly or substantially) modified peptides, we chose to focus on unmodified ones, as we aimed to decipher intrinsic characteristics of peptide proteolytic susceptibility. Specifically, we developed a multivariable regression model to unravel those peptide properties with most impact on proteolytic stability and thus potential t1/2 predicting ability. Model validation was done by two different approaches. First, a library of peptides spanning a large interval of properties that modulate stability was synthesized and their t1/2 in human serum were experimentally determined. Second, the t1/2 of 21 selected peptides approved for clinical use or in clinical trials were recorded and matched with the model-estimated values. With both approaches, good correlation between experimental and predicted t1/2 data was observed., This research was supported by the Portuguese Fundação para a Ciência e a Tecnologia (FCT; grants PD/BD/128281/2017, PTDC/BBB‐NAN/1578/2014, PTDC/BIA‐VIR/29495/2017, UID/Multi/04349/2019, and PTDC/QUI‐NUC/30147/2017), the Spanish Ministry of Economy and Innovation (MINECO, grants AGL2014‐52395‐C2‐2‐R and AGL2017‐84097‐C2‐2‐R, and Maria de Maeztu Program for Centers of Excellence); the European Union H2020‐MSCA‐RISE‐2014 program (grant no. 828774), and the “La Caixa” Banking Foundation (grant HR17‐00409).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

  • Cebrià i Costa, Joan Pau, 1989-
  • Pascual-Reguant, Laura, 1990-
  • Gonzalez-Perez, Abel
  • Serra Bardenys, Gemma, 1992-
  • Querol, J.
  • Cosín Tomàs, Marta
  • Verde, Gaetano
  • Cigliano, Riccardo Aiese
  • Sanseverino, Walter
  • Segura-Bayona, Sandra
  • Iturbide Martínez de Albéniz, Ane, 1989-
  • Andreu Martínez, David
  • Nuciforo, Paolo G.
  • Bernado-Morales, C.
  • Rodilla, Verónica
  • Arribas, Joaquín
  • Yélamos López, José
  • García de Herreros, Antonio
  • Stracker, Travis
  • Peiró Sales, Sandra
Oxidation of H3 at lysine 4 (H3K4ox) by lysyl oxidase-like 2 (LOXL2) generates an H3 modification with an unknown physiological function. We find that LOXL2 and H3K4ox are higher in triple-negative breast cancer (TNBC) cell lines and patient-derived xenografts (PDXs) than those from other breast cancer subtypes. ChIP-seq revealed that H3K4ox is located primarily in heterochromatin, where it is involved in chromatin compaction. Knocking down LOXL2 reduces H3K4ox levels and causes chromatin decompaction, resulting in a sustained activation of the DNA damage response (DDR) and increased susceptibility to anticancer agents. This critical role that LOXL2 and oxidized H3 play in chromatin compaction and DDR suggests that functionally targeting LOXL2 could be a way to sensitize TNBC cells to conventional therapy., This work was supported by grants from Instituto de Salud Carlos III (ISCIII) FIS/FEDER (PI12/01250; CP08/00223; PI16/00253; and CB16/12/00449), MINECO (SAF2013-48849-C2-1-R) to SP, BFU2015-68354 to THS, Breast Cancer Research Foundation (BCRF-17-008) to JA, AGL2014-52395-C2-2-R to DA, Worldwide Cancer Research, Red Temática de Investigación Cooperativa en Cáncer (RD012/0036/005), Fundación Científica de la Asociación Española contra el Cáncer, and Fundació La Marató TV3.THS was supported by institutional funding (MINECO) through theCentres of Excellence Severo Ochoa award and the CERCA Pro-gramme of the Catalan Government, and SS-B, by a Fundació LaCaixa fellowship. We thank La Caixa Foundation and Cellex Foun-dation for provide research facilities and equipment. GV has received f unding from the MINECO (a “Juan de la Cierva Incorporation ” fellowship; IJCI-2014-20723). SP was a recipient of a Miguel Servet contract (ISCIII/FIS), and AI, JPC-C, LP-G, and GS-B are supported by contracts from Worldwide Cancer Research, Fundació La MaratóTV3, Fundació FERO, and a FI Fellowship from the Generalitat de Catalunya, respectively.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Lectin-binding specificity of the fertilization-relevant protein PDC-109 by means of surface plasmon resonance and carbohydrate recognition domain excision-mass spectrometry

  • Defaus, Sira
  • Avilés, Manuel
  • Andreu Martínez, David
  • Gutiérrez Gallego, Ricardo, 1968-
Seminal plasma proteins are relevant for sperm functionality and some appear responsible for establishing sperm interactions with the various environments along the female genital tract towards the oocyte. In recent years, research has focused on characterizing the role of these proteins in the context of reproductive biology, fertility diagnostics and treatment of related problems. Herein, we focus on the main protein of bovine seminal plasma, PDC-109 (BSP-A1/-A2), which by virtue of its lectin properties is involved in fertilization. By means of surface plasmon resonance, the interaction of PDC-109 with a panel of the most relevant glycosidic epitopes of mammals has been qualitatively and quantitatively characterized, and a higher affinity for carbohydrates containing fucose has been observed, in line with previous studies. Additionally, using the orthogonal technique of Carbohydrate REcognition Domain EXcision-Mass Spectrometry (CREDEX-MS), the recognition domain of the interaction complexes between PDC-109 and all fucosylated disaccharides [(Fuc-α1,(3,4,6)-GlcNAc)] has been defined, revealing the specific glycotope and the peptide domain likely to act as the PDC-109 carbohydrate binding site., This work was supported by grants BIO2009-08983 from MICINN (to R.G.G.), SAF2011-24899, AGL 2015-70159-P [FEDER] from MINECO (to Manuel Avilés) and AGL 2014-52395-C2-2-R [FEDER] from MINECO, and SGR2009 - 00492 from Generalitat de Catalunya (to David Andreu). PDC-109, purified from bull seminal plasma, was kindly donated by Juan José Calvete.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Amyloid-β peptide nitrotyrosination stabilizes oligomers and enhances NMDAR-mediated toxicity

  • Guivernau Almazán, Biuse, 1988-
  • Bonet Martínez, Jaume, 1982-
  • Valls Comamala, Victòria, 1987-
  • Bosch Morató, Mònica, 1986-
  • Godoy Zeballos, Juan Alejandro, 1959-
  • Inestrosa, Nibaldo C.
  • Perálvarez Marín, Alex
  • Fernández-Busquets, Xavier
  • Andreu Martínez, David
  • Oliva Miguel, Baldomero
  • Muñoz López, Francisco José, 1964-
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the pathological aggregation of the amyloid-β peptide (Aβ). Monomeric soluble Aβ can switch from helicoidal to β-sheet conformation, promoting its assembly into oligomers and subsequently to amyloid fibrils. Oligomers are highly toxic to neurons and have been reported to induce synaptic transmission impairments. The progression from oligomers to fibrils forming senile plaques is currently considered a protective mechanism to avoid the presence of the highly toxic oligomers. Protein nitration is a frequent post-translational modification under AD nitrative stress conditions. Aβ can be nitrated at tyrosine 10 (Y10) by peroxynitrite. Based on our analysis of ThT binding, Western blot and electron and atomic force microscopy, we report that Aβ nitration stabilizes soluble, highly toxic oligomers and impairs the formation of fibrils. We propose a mechanism by which fibril elongation is interrupted upon Y10 nitration: Nitration disrupts fibril-forming folds by preventing H14-mediated bridging, as shown with an Aβ analog containing a single residue (H to E) replacement that mimics the behavior of nitrated Aβ related to fibril formation and neuronal toxicity. The pathophysiological role of our findings in AD was highlighted by the study of these nitrated oligomers on mouse hippocampal neurons, where an increased NMDAR-dependent toxicity of nitrated Aβ oligomers was observed. Our results show that Aβ nitrotyrosination is a post-translational modification that increases Aβ synaptotoxicity. SIGNIFICANCE STATEMENT: We report that nitration (i.e., the irreversible addition of a nitro group) of the Alzheimer-related peptide amyloid-β (Aβ) favors the stabilization of highly toxic oligomers and inhibits the formation of Aβ fibrils. The nitrated Aβ oligomers are more toxic to neurons due to increased cytosolic calcium levels throughout their action on NMDA receptors. Sustained elevated calcium levels trigger excitotoxicity, a characteristic event in Alzheimer's disease., This work was supported by Spanish Plan Estatal de I+D+I 2013-2016 and the ISCIII-Subdirección General de Evaluación y Fomento de la Investigación Grants PI13/00408 and Red HERACLES RD12/0042/0014 and FEDER Funds, Spanish Ministerio de Economía y Competitividad BIO2014-57518-R, BIO2014-52872-R, and AGL2014-52395-C2-2-R and FEDER Funds, the Generalitat de Catalunya (Spain) 2014-SGR-938, and Chilean Funds for Science CONICYTPFB 12/2007 and FONDECYT N° 1160724. A.P.-M. was the recipient of the Universitat Autònoma de Barcelona-Programa Banco de Santander Fellowship
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins

  • Dias, Susana A.
  • Miguel Freire, João
  • Pérez-Peinado, Clara, 1991-
  • Domingues, Marco M.
  • Gaspar, Diana
  • Vale, Nuno
  • Gomes, Paula
  • Andreu Martínez, David
  • Henriques, Sónia T.
  • Castanho, Miguel A.R.B.
  • Veiga, Ana Salomé
The increasing prevalence of multidrug-resistant bacteria urges the development of new antibacterial agents. With a broad spectrum activity, antimicrobial peptides have been considered potential antibacterial drug leads. Using bioinformatic tools we have previously shown that viral structural proteins are a rich source for new bioactive peptide sequences, namely antimicrobial and cell-penetrating peptides. Here, we test the efficacy and mechanism of action of the most promising peptides among those previously identified against both Gram-positive and Gram-negative bacteria. Two cell-penetrating peptides, vCPP 0769 and vCPP 2319, have high antibacterial activity against Staphylococcus aureus, MRSA, Escherichia coli, and Pseudomonas aeruginosa, being thus multifunctional. The antibacterial mechanism of action of the two most active viral protein-derived peptides, vAMP 059 and vCPP 2319, was studied in detail. Both peptides act on both Gram-positive S. aureus and Gram-negative P. aeruginosa, with bacterial cell death occurring within minutes. Also, these peptides cause bacterial membrane permeabilization and damage of the bacterial envelope of P. aeruginosa cells. Overall, the results show that structural viral proteins are an abundant source for membrane-active peptides sequences with strong antibacterial properties., This work was supported by Fundação para a Ciência e a Tecnologia (FCT-MCTES, Portugal) projects PTDC/QEQ-MED/4412/2014 and UID/QUI/50006/2013, and by Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE): call H2020-MSCA-RISE-2014, Grant agreement 644167, 2015–2019. SD, JF, and DG acknowledge FCT for fellowships PD/BD/114425/2016, SFRH/BD/70423/2010, and SFRH/BPD/109010/2015, respectively, and MD for a grant (PTDC/BBB-BQB/3494/2014). ASV and NV acknowledge FCT for funding within the FCT Investigator Programme, IF/00803/2012 and IF/00092/2014, respectively. CP-P acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through grant AGL2014-52395-C2-2-R and the “María de Maeztu” Programme for Units of Excellence in R&D (MDM-2014-0370). PG acknowledges “Comissão de Coordenação e Desenvolvimento Regional do Norte (CCDR-N)/NORTE2020/Portugal 2020” for funding through project DESignBIOtechHealth (ref. Norte-01-0145-FEDER-000024). SH is the recipient of an Australian Research Council Future Fellowship (FT150100398).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A bivalent dendrimeric peptide bearing a T-cell epitope from foot-and-mouth disease virus protein 3A improves humoral response against classical swine fever virus

  • Bohórquez, José Alejandro
  • Defaus, Sira
  • Muñoz González, Sara
  • Perez-Simó, Marta
  • Rosell, Rosa
  • Fraile Sauce, Lorenzo José
  • Sobrino, Francisco
  • Andreu, David
  • Ganges, Llilianne
Three dendrimeric peptides were synthesized in order to evaluate their immunogenicity and their potential protection against classical swine fever virus (CSFV) in domestic pigs. Construct 1, an optimized version of a previously used dendrimer, had four copies of a B-cell epitope derived from CSFV E2 glycoprotein connected to an also CSFV-derived T-cell epitope through maleimide instead of thioether linkages. Construct 2 was similarly built but included only two copies of the B-cell epitope, and in also bivalent construct 3 the CSFV T-cell epitope was replaced by a previously described one from the 3A protein of foot-and-mouth disease virus (FMDV). Animals were inoculated twice with a 21-day interval and challenged 15days after the second immunization. Clinical signs were recorded daily and ELISA tests were performed to detect antibodies against specific peptide and E2. The neutralising antibody response was assessed 13days after challenge. Despite the change to maleimide connectivity, only partial protection against CSFV was again observed. The best clinical protection was observed in group 3. Animals inoculated with constructs 2 and 3 showed higher anti-peptide humoral response, suggesting that two copies of the B-cell epitope are sufficient or even better than four copies for swine immune recognition. In addition, for construct 3 higher neutralizing antibody titres against CSFV were detected. Our results support the immunogenicity of the CSFV B-cell epitope and the cooperative role of the FMDV 3A T-cell epitope in inducing a neutralising response against CSFV in domestic pigs. This is also the first time that the FMDV T-cell epitope shows effectivity in improving swine immune response against a different virus. Our findings highlight the relevance of dendrimeric peptides as a powerful tool for epitope characterization and antiviral strategies development., The research in CReSA was supported by grant AGL2015-66907 from the Spanish government. J.A. B. had a pre-doctoralfellowship FPI-MINECO 2016 from Spanish government. S. M.had a pre-doctoral fellowship FI-DGR 2014 from AGAUR, Gen-eralitat de Catalunya. Work at CBMSO was supported by grantsAGL2014-52395-C2-01 (MINECO, Spain) and S2013/ABI-2906-PLATESA (Comunidad Autónoma de Madrid). Work at UPF wasfunded by AGL2014-52395-C2-02 (MINECO, Spain).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Co-administration of antimicrobial peptides enhances toll-like receptor 4 antagonist activity of a synthetic glycolipid

  • Facchini, Fabio A.
  • Coelho, Helena
  • Sestito, Stefania Enza
  • Delgado, Sandra
  • Minotti, Alberto
  • Andreu Martínez, David
  • Jiménez-Barbero, Jesús J.
  • Peri, Francesco
This study examines the effect of co-administration of antimicrobial peptides and the synthetic glycolipid FP7, which is active in inhibiting inflammatory cytokine production caused by TLR4 activation and signaling. The co-administration of two lipopolysaccharide (LPS)-neutralizing peptides (a cecropin A-melittin hybrid peptide and a human cathelicidin) enhances by an order of magnitude the potency of FP7 in blocking the TLR4 signal. Interestingly, this is not an additional effect of LPS neutralization by peptides, because it also occurs if cells are stimulated by the plant lectin phytohemagglutinin, a non-LPS TLR4 agonist. Our data suggest a dual mechanism of action for the peptides, not exclusively based on LPS binding and neutralization, but also on a direct effect on the LPS-binding proteins of the TLR4 receptor complex. NMR experiments in solution show that peptide addition changes the aggregation state of FP7, promoting the formation of larger micelles. These results suggest a relationship between the aggregation state of lipid A-like ligands and the type and intensity of the TLR4 response., This study was financially supported by the H2020‐MSC‐ETN‐642157 project TOLLerant. The Italian Ministry for Foreign Affairs and International Cooperation (MAECI) is acknowledged. Work at Pompeu Fabra University was supported by MINECO (grants SAF2011‐24899, AGL2014‐52395‐C2‐2‐R to D.A., CTQ2015‐64597‐C2‐1‐P and MINECO‐Severo Ochoa Excellence Acreditation 2017-2021 (SEV‐2016‐0644) to J.J.‐B.) with FEDER funds, and by Generalitat de Catalunya (2014SGR692).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells

  • Cebrià Costa, Joan Pau|||0000-0002-3628-2973
  • Pascual Reguant, Laura|||0000-0003-2361-1392
  • Gonzalez-Perez, Abel|||0000-0002-8582-4660
  • Serra-Bardenys, Gemma
  • Querol, Jessica|||0000-0002-0527-759X
  • Cosín Tomás, Marc
  • Verde, Gaetano|||0000-0003-4768-0165
  • Aiese Cigliano, Riccardo|||0000-0002-9058-6994
  • Sanseverino, Walter|||0000-0003-3324-5912
  • Segura-Bayona, Sandra|||0000-0001-7788-9889
  • Iturbide, Ane
  • Andreu Martínez, David|||0000-0002-6317-6666
  • Nuciforo, Paolo|||0000-0003-1380-0990
  • Bernadó Morales, Cristina|||0000-0003-1376-0407
  • Rodilla, Verónica|||0000-0003-0512-4179
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Yélamos, José|||0000-0003-1195-1496
  • Garcia de Herreros, Antonio|||0000-0001-5270-0808
  • Stracker, Travis H.|||0000-0002-8650-2081
  • Peiró, Sandra|||0000-0001-9519-3877
Oxidation of H3 at lysine 4 (H3K4ox) by lysyl oxidase-like 2 (LOXL2) generates an H3 modification with an unknown physiological function. We find that LOXL2 and H3K4ox are higher in triple-negative breast cancer (TNBC) cell lines and patient-derived xenografts (PDXs) than those from other breast cancer subtypes. ChIP-seq revealed that H3K4ox is located primarily in heterochromatin, where it is involved in chromatin compaction. Knocking down LOXL2 reduces H3K4ox levels and causes chromatin decompaction, resulting in a sustained activation of the DNA damage response (DDR) and increased susceptibility to anticancer agents. This critical role that LOXL2 and oxidized H3 play in chromatin compaction and DDR suggests that functionally targeting LOXL2 could be a way to sensitize TNBC cells to conventional therapy.